Maija Lappalainen

6.5k total citations
128 papers, 4.0k citations indexed

About

Maija Lappalainen is a scholar working on Epidemiology, Infectious Diseases and Parasitology. According to data from OpenAlex, Maija Lappalainen has authored 128 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Epidemiology, 57 papers in Infectious Diseases and 23 papers in Parasitology. Recurrent topics in Maija Lappalainen's work include Cytomegalovirus and herpesvirus research (40 papers), Herpesvirus Infections and Treatments (31 papers) and Toxoplasma gondii Research Studies (21 papers). Maija Lappalainen is often cited by papers focused on Cytomegalovirus and herpesvirus research (40 papers), Herpesvirus Infections and Treatments (31 papers) and Toxoplasma gondii Research Studies (21 papers). Maija Lappalainen collaborates with scholars based in Finland, Sweden and United States. Maija Lappalainen's co-authors include Klaus Hedman, O. Mäkelä, Pentti Koskela, Birgitta Evengård, Heli Piiparinen, Anne J. Jääskeläinen, Marjaleena Koskiniemi, Benjamin Edvinsson, Leena Maunula and Merja Roivainen and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Maija Lappalainen

123 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maija Lappalainen Finland 35 2.0k 1.5k 1.3k 435 308 128 4.0k
Andreas Sauerbrei Germany 37 2.6k 1.3× 980 0.7× 409 0.3× 344 0.8× 281 0.9× 172 3.8k
Todd F. Hatchette Canada 31 1.2k 0.6× 1.3k 0.9× 465 0.4× 335 0.8× 123 0.4× 139 2.7k
Antonella Sarasini Italy 39 3.5k 1.7× 2.4k 1.6× 575 0.4× 170 0.4× 421 1.4× 108 4.7k
Elisabeth Puchhammer‐Stöckl Austria 36 1.8k 0.9× 1.4k 0.9× 282 0.2× 252 0.6× 550 1.8× 136 3.6k
Aisha O. Jumaan United States 31 2.9k 1.4× 893 0.6× 908 0.7× 148 0.3× 140 0.5× 54 3.9k
Rafael Harpaz United States 40 5.1k 2.5× 1.3k 0.9× 1.2k 0.9× 239 0.5× 139 0.5× 95 6.9k
Sophie Alain France 31 2.5k 1.2× 999 0.7× 309 0.2× 213 0.5× 430 1.4× 154 3.4k
Marianne Forsgren Sweden 39 3.1k 1.5× 2.2k 1.5× 1.2k 0.9× 318 0.7× 250 0.8× 152 5.8k
David W. Kimberlin United States 41 5.8k 2.9× 2.6k 1.8× 486 0.4× 441 1.0× 283 0.9× 153 7.1k
Stephan W. Aberle Austria 36 1.4k 0.7× 1.8k 1.2× 360 0.3× 314 0.7× 238 0.8× 121 3.2k

Countries citing papers authored by Maija Lappalainen

Since Specialization
Citations

This map shows the geographic impact of Maija Lappalainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maija Lappalainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maija Lappalainen more than expected).

Fields of papers citing papers by Maija Lappalainen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maija Lappalainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maija Lappalainen. The network helps show where Maija Lappalainen may publish in the future.

Co-authorship network of co-authors of Maija Lappalainen

This figure shows the co-authorship network connecting the top 25 collaborators of Maija Lappalainen. A scholar is included among the top collaborators of Maija Lappalainen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maija Lappalainen. Maija Lappalainen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bajamundi, Cyril, et al.. (2025). Production of high-concentration CO2 from electrified limestone calcination for carbon capture applications. International journal of greenhouse gas control. 149. 104559–104559.
2.
Mizohata, Kenichiro, et al.. (2025). Accelerator mass spectrometry for tracing fossil carbon content of combusted fuel. Applied Radiation and Isotopes. 225. 111996–111996.
3.
Paloniemi, Minna, Timo Vesikari, Maija Lappalainen, et al.. (2021). Human Protoparvovirus DNA and IgG in Children and Adults with and without Respiratory or Gastrointestinal Infections. Viruses. 13(3). 483–483. 13 indexed citations
4.
Jääskeläinen, Anu, Maarit J. Ahava, Pia Jokela, et al.. (2021). Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection. Journal of Clinical Virology. 137. 104785–104785. 46 indexed citations
5.
Smura, Teemu, Soile Blomqvist, Pekka Kolehmainen, et al.. (2020). Aseptic meningitis outbreak associated with echovirus 4 in Northern Europe in 2013–2014. Journal of Clinical Virology. 129. 104535–104535. 4 indexed citations
6.
Jarva, Hanna, et al.. (2020). Saliva‐based testing for diagnosis of SARS‐CoV‐2 infection: A meta‐analysis. Journal of Medical Virology. 93(3). 1256–1258. 12 indexed citations
7.
Puhakka, Laura, et al.. (2017). Immunity against vaccine-preventable diseases in Finnish pediatric healthcare workers in 2015. Vaccine. 35(12). 1608–1614. 22 indexed citations
8.
Roine, Irmeli, Tuula Pelkonen, Anneli Lauhio, et al.. (2015). Changes in MMP-9 and TIMP-1 Concentrations in Cerebrospinal Fluid after 1 Week of Treatment of Childhood Bacterial Meningitis. Journal of Clinical Microbiology. 53(7). 2340–2342. 10 indexed citations
9.
Puhakka, Laura, Emmi Sarvikivi, Maija Lappalainen, Heljä‐Marja Surcel, & Harri Saxén. (2015). Decrease in seroprevalence for herpesviruses among pregnant women in Finland: cross-sectional study of three time points 1992, 2002 and 2012. Infectious Diseases. 48(5). 406–410. 41 indexed citations
10.
Huovinen, Elisa, Mikko Virtanen, Salla Toikkanen, et al.. (2014). Hepatiitti C -virusinfektioiden seuranta Suomessa vuosina 1995-2013. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 139(5). 603–603. 1 indexed citations
11.
Roine, Irmeli, Tuula Pelkonen, Luís Bernardino, et al.. (2014). Predictive Value of Cerebrospinal Fluid Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Concentrations in Childhood Bacterial Meningitis. The Pediatric Infectious Disease Journal. 33(7). 675–679. 14 indexed citations
12.
Kolehmainen, Pekka, Anne J. Jääskeläinen, Soile Blomqvist, et al.. (2014). Human Parechovirus Type 3 and 4 Associated With Severe Infections in Young Children. WOS. 1 indexed citations
13.
Jääskeläinen, Anne J., Pekka Kolehmainen, Liina Voutilainen, et al.. (2013). Evidence of ljungan virus specific antibodies in humans and rodents, Finland. Journal of Medical Virology. 85(11). 2001–2008. 17 indexed citations
14.
Sillanpää, M, Elisa Huovinen, Mikko Virtanen, et al.. (2013). Epidemiology of hepatitis C virus infections in Finland between the years 1995 and 2011. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari).
15.
Mannonen, Laura, Raija Vainionpää, Juha Kauppinen, et al.. (2012). Evaluation of multiplex polymerase chain reaction and microarray-based assay for rapid herpesvirus diagnostics. Diagnostic Microbiology and Infectious Disease. 73(1). 74–79. 16 indexed citations
16.
Pulkkinen, Ville, Kaisa Salmenkivi, Vuokko L. Kinnula, et al.. (2011). A novel screening method detects herpesviral DNA in the idiopathic pulmonary fibrosis lung. Annals of Medicine. 44(2). 178–186. 27 indexed citations
17.
Ikonen, Niina, Esa Rönkkö, Outi Lyytikäinen, et al.. (2010). Genetic Diversity of the 2009 Pandemic Influenza A(H1N1) Viruses in Finland. PLoS ONE. 5(10). e13329–e13329. 42 indexed citations
18.
Hemminki, Otto, Gerd Bauerschmitz, Silvio Hemmi, et al.. (2010). Oncolytic adenovirus based on serotype 3. Cancer Gene Therapy. 18(4). 288–296. 47 indexed citations
19.
Lautenschlager, Irmeli, Maija Lappalainen, Kimmo Linnavuori, Jukka Suni, & Krister Höckerstedt. (2002). CMV infection is usually associated with concurrent HHV-6 and HHV-7 antigenemia in liver transplant patients. Journal of Clinical Virology. 25. 57–61. 56 indexed citations
20.
Pelloux, Hervé, Edward Guy, Maria Cristina Angelici, et al.. (1998). A second European collaborative study on polymerase chain reaction forToxoplasma gondii, involving 15 teams. FEMS Microbiology Letters. 165(2). 231–237. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Sauerbrei Breakdown of academic impact, for papers by Todd F. Hatchette Breakdown of academic impact, for papers by Antonella Sarasini Breakdown of academic impact, for papers by Elisabeth Puchhammer‐Stöckl Breakdown of academic impact, for papers by Aisha O. Jumaan Breakdown of academic impact, for papers by Rafael Harpaz Breakdown of academic impact, for papers by Sophie Alain Breakdown of academic impact, for papers by Marianne Forsgren Breakdown of academic impact, for papers by David W. Kimberlin Breakdown of academic impact, for papers by Stephan W. Aberle
Rankless by CCL
2026